Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from Pharmacovigilance

The advent of immune checkpoint inhibitors (ICIs) caused a paradigm shift both in drug development and clinical practice; however, by virtue of their mechanism of action, the excessively activated immune system results in a multitude of off-target toxicities, the so-called immune-related adverse eve...

Descripción completa

Detalles Bibliográficos
Autores principales: Raschi, Emanuel, Gatti, Milo, Gelsomino, Francesco, Ardizzoni, Andrea, Poluzzi, Elisabetta, De Ponti, Fabrizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434791/
https://www.ncbi.nlm.nih.gov/pubmed/32725437
http://dx.doi.org/10.1007/s11523-020-00738-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434791/
https://www.ncbi.nlm.nih.gov/pubmed/32725437
http://dx.doi.org/10.1007/s11523-020-00738-6

Ejemplares similares